Clinical challenges and dilemmas in the management of advanced pancreatic neuroendocrine tumour - the first manifestation of von Hippel-Lindau disease in a young patient

Endokrynol Pol. 2021;72(4):412-413. doi: 10.5603/EP.a2021.0052. Epub 2021 May 19.

Authors

Karolina Morawiec-Sławek¹, Marta Opalińska², Agnieszka Stefańska², Anna Sowa-Staszczak¹, Alicja Hubalewska-Dydejczyk³

Affiliations

¹ Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland.
² Chair and Department of Endocrinology, University Hospital, Krakow, Poland.
³ Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland. alahub@cm-uj.krakow.pl.

PMID: 34010452
DOI: 10.5603/EP.a2021.0052

Abstract

Not required for Clinical Vignette.

Keywords: pNET; somatostatin analogues; von Hippel-Lindau disease.

MeSH terms

Humans
Neuroendocrine Tumors*
Pancreatic Neoplasms* / drug therapy
von Hippel-Lindau Disease* / complications